CORPORATE INFO
FOR INVESTORS
OUR PRODUCTS
BUSINESS DEVELOPMENT
CONTACT US
HOME
Menu
Overview
Mission Statement
Strategy
History
Management Team
Board of Directors
News
Press Releases
Corporate News
Awards
PRESS RELEASES
COMMUNIQUÉS DE PRESSE (Français)
2013
|
2012
|
2011
|
2010
|
2009
|
2008
|
2007
|
2006
|
2005
|
2004
|
2003
|
2002
|
2001
|
2000
|
1999
|
1998
|
1997
|
December 23, 2008
PALADIN LABS INC. ACQUIRED VIREXX MEDICAL CORP.
(Also in
PDF
format)
December 22, 2008
PROSTRAKAN AND PALADIN COMPLETE AGREEMENT FOR ABSTRAL(R) AND SANCUSO(R)
(Also in
PDF
format)
December 15, 2008
PALADIN LABS ANNOUNCES AUTOMATIC SHARE PURCHASE PLAN
(Also in
PDF
format)
November 28, 2008
PALADIN LABS AND GLAXOSMITHKLINE INC. SIGN AGREEMENT ON DEXEDRINE(R) AND MARK START OF A NEW STRATEGIC RELATIONSHIP
(Also in
PDF
format)
November 6, 2008
PALADIN REPORTS RECORD THIRD QUARTER 2008 FINANCIAL RESULTS
(Also in
PDF
format)
October 30, 2008
NOTICE OF PALADIN LABS' THIRD QUARTER RESULTS CONFERENCE CALL
(Also in
PDF
format)
September 25, 2008
PALADIN TO PRESENT AT BIOCONTACT CONFERENCE IN QUEBEC CITY
(Also in
PDF
format)
September 19, 2008
PALADIN TO PRESENT AT THE UBS GLOBAL LIFE SCIENCE CONFERENCE IN NEW YORK
(Also in
PDF
format)
September 17, 2008
PALADIN TO PRESENT AT CIBC WORLD MARKETS 7TH ANNUAL EASTERN INSTITUTIONAL INVESTOR CONFERENCE
(Also in
PDF
format)
August 7, 2008
PALADIN REPORTS 2008 SECOND QUARTER FINANCIAL RESULTS
(Also in
PDF
format)
July 31, 2008
NOTICE OF PALADIN LABS' SECOND QUARTER RESULTS CONFERENCE CALL
(Also in
PDF
format)
July 8, 2008
NUVO RESEARCH AND PALADIN ANNOUNCE AMENDMENTS TO PENNSAID AND PENNSAID PLUS AGREEMENTS
(Also in
PDF
format)
July 2, 2008
PALADIN LABS AND PROCTER & GAMBLE PHARMACEUTICALS ENTER INTO CANADIAN CO-PROMOTION AGREEMENT FOR SEASONALE(TM): FIRST AND ONLY EXTENDED-CYCLE ORAL CONTRACEPTIVE AVAILABLE IN CANADA
June 3, 2008
PALADIN LABS INC.: NEW IMPROVED DOSING APPROVED FOR PENNSAID(R)
(Also in
PDF
format)
May 29, 2008
NUVO LICENSES TOPICAL PAIN PRODUCT FROM PALADIN
(Also in
PDF
format)
May 15, 2008
PALADIN LABS INC.: PLAN B(R) EMERGENCY CONTRACEPTIVE NOW OVER THE COUNTER IN CANADA
(Also in
PDF
format)
May 15, 2008
PALADIN REPORTS 2008 FIRST QUARTER FINANCIAL RESULTS
May 8, 2008
NOTICE OF PALADIN LABS' FIRST QUARTER RESULTS CONFERENCE CALL
(Also in
PDF
format)
April 14, 2008
PALADIN LABS INC.: CANADIAN WOMEN TO BE GRANTED EASIER ACCESS TO EMERGENCY CONTRACEPTION
(Also in
PDF
format)
April 1, 2008
AETERNA ZENTARIS AND PALADIN LABS COMPLETE SALE AND PURCHASE OF MILTEFOSINE RIGHTS
(Also in
PDF
format)
March 3, 2008
AETERNA ZENTARIS AND PALADIN LABS ANNOUNCE SALE AND PURCHASE OF MILTEFOSINE RIGHTS
(Also in
PDF
format)
February 29, 2008
PALADIN FILES NEW DRUG SUBMISSION FOR SEASONIQUE(R)
(Also in
PDF
format)
February 28, 2008
PALADIN ANNOUNCES NORMAL COURSE ISSUER BID
(Also in
PDF
format)
February 28, 2008
PALADIN REPORTS RECORD 2007 FOURTH QUARTER AND YEAR END RESULTS
(Also in
PDF
format)
February 21, 2008
NOTICE OF PALADIN LABS' FOURTH QUARTER AND 2007 YEAR-END RESULTS CONFERENCE CALL
(Also in
PDF
format)
February 19, 2008
PALADIN TO PRESENT AT THE ROTH CAPITAL PARTNERS 20TH ANNUAL OC GROWTH STOCK CONFERNCE
(Also in
PDF
format)
February 18, 2008
PALADIN LABS & KV PHARMACEUTICALS SIGN DISTRIBUTION FOR MICRO-K(R) EXTENCAPS(R) CAPSULES
(Also in
PDF
format)
January 31, 2008
PALADIN AND NYCOMED ENTER INTO CANADIAN CO-PROMOTION AGREEMENT FOR TRIDURAL(TM) ONCE-DAILY TRAMADOL PRODUCT
(Also in
PDF
format)
January 4, 2008
PALADIN LABS ANNOUNCES SEASONALE LAUNCH
(Also in
PDF
format)
HOME
|
SITE MAP
|
LEGAL DISCLAIMER
